Completed

NCT Number: NCT00662324

Development of a Clinical Trial Specific Question Prompt List

The purpose of this study is to develop a Question Prompt List (QPL) about clinical trials for cancer patients and find out what cancer patients and their caregivers think of the QPL. A QPL is a list of questions patients might want to ask their doctors during their appointments.

We will conduct three focus groups to talk about using QPL's as a new way to recruit patients like you to clinical trials. The three groups will be made of patients who have and have not participated in clinical trials, their caregivers and doctors. This study is also being done to learn about how the QPL affects the question asking behavior of patients during their appointments with doctors at Memorial SloanKettering Cancer Center (MSKCC).

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Breast Cancer Breast Diseases Breast Neoplasms Genital Diseases Genital Diseases, Male Genital Neoplasms, Male Lung Cancer Lung Diseases Lung Neoplasms Male Urogenital Diseases Neoplasms Neoplasms by Site Prostate Cancer Prostatic Diseases Prostatic Neoplasms Respiratory Tract Diseases Respiratory Tract Neoplasms Skin Diseases Skin and Connective Tissue Diseases Thoracic Neoplasms Urogenital Diseases Urogenital Neoplasms

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Memorial Sloan-Kettering Cancer Center

New York, 10065, United States

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Population Segment 1 who have participated in a clinical trial
Diagnosis and treatment at MSKCC of lung, prostate or breast cancer
Completion of a Phase I, II, or III clinical trial at MSKCC
Ability to provide informed consent

Patient caregiver eligibility requirements will be:

Nomination by patient as the primary caregiver
Ability to provide informed consent

Population Segment 2 who have not participated in a clinical trial:

Diagnosis and treatment at MSKCC of lung, prostate or breast cancer or the primary patient caregiver
Ability to provide informed consent

Patient caregiver eligibility requirements will be:

Nomination by patient as the primary caregiver
Ability to provide informed consent

Population Segment 3 who are health care professionals:

A current health care professional at MSKCC
Current involvement in recruiting patients with lung, prostate or breast cancer to Phase I,II, or III clinical trials at MSKCC
Ability to provide informed consent

Exclusion criteria

Potential subjects will be considered ineligible for either/both phases of this study if they are:

Fewer than 18 years of age
Cognitively or physically impaired, rendering them incapable of providing informed consent to participate in the study
Population Segment 2 participants will be excluded if they have ever participated in a clinical trial.

Treatment and study plan

Focus Groups

Behavioral

Focus group with MSKCC patients with lung, breast and prostate cancer who have taken part in clinical trials and other caregivers. This focus group will be audio recorded.

During the focus group, you will discuss a Question Prompt List that will be handed out to you. You will be asked about what you think of it and if you think it would have been useful to the patient you care for in his/her experience in a clinical trial.

The focus group to last from 60 to 90 minutes.

Primary outcomes

To develop a targeted Question Prompt List for Clinical Trials and evaluate its acceptability to cancer patients considering clinical trial participation.

Time frame: conclusion of study

Secondary outcomes

To explore the utility of the Question Prompt List for Clinical Trials in oncology consultations containing a discussion of a Phase I, II or III clinical trial.

Time frame: conclusion of study

Sponsors and collaborators

Lead sponsor

Memorial Sloan Kettering Cancer Center

Other

Collaborators

National Cancer Institute (NCI)
National Institutes of Health (NIH)
Virginia Commonwealth University

Registry information

Important dates

Study start: 2008
Primary completion: 2013
Study completion: 2013
First posted: Apr 21, 2008
Registry last updated: May 30, 2013

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed